peptide therapeutic (Atorvia/Boston University)

N/A

Report date: 2025/06/11 10:45:14

Base Information

Drug Namepeptide therapeutic (Atorvia/Boston University)
Drug Alias Namenucleophosmin (NPM) inhibitor (Atorvia/Boston University)peptide therapeutic (Boston University)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNucleophosmin inhibitors
TargetsNucleophosmin
Therapy Area/IndicationsRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBoston University
China Registration ClassN/A

Develop Information

Active CompaniesAtorvia Health Technologies LLCBoston University
Inactive CompaniesN/A
Active IndicationsRenal Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A